Attached files
file | filename |
---|---|
10-K - ANNUAL REPORT - PharmaCyte Biotech, Inc. | pharmacyte_10k-043015.htm |
EX-31.1 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex3101.htm |
EX-23.2 - CONSENT - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex2302.htm |
EX-32.1 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex3201.htm |
EX-21.1 - LIST OF SUBSIDIARIES - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex2101.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
PharmaCyte Biotech, Inc.
(Formerly Nuvilex, Inc.)
Silver Spring, Maryland
We hereby consent to the incorporation by reference in the Registration Statement on Amendment No.1 to Form S-3 (No. 333-199440) of PharmaCyte Biotech, Inc., formerly Nuvilex, Inc. (the “Company”), of our reports dated July 28, 2015, relating to the consolidated financial statements and schedule as of April 30, 2015 and for the year then ended and the effectiveness of the Company’s internal control over financial reporting as of April 30, 2015, which appears in this Form 10-K.
/s/ Farber Hass Hurley LLP
Chatsworth, California
July 28, 2015